pragma.vision Technology observatory & strategic foresight

Verification register Bio, Health & Neuro

Living definition

What is Life Biosciences ER-100 (Partial Epigenetic Reprogramming)?

Longevity & Aging Biotech Bio, Health & Neuro

As of
2026-08-20
Revision
2026-08-17.1
Method
v1.3.0

Definition

The term, in context

AI-assisted draft · approved dataset

Life Biosciences ER-100 is an experimental gene therapy that partially resets a cell’s epigenetic markers, aiming to reverse age-related cellular changes without erasing the cell’s identity.

Live readiness status

Status as of the current dateline

AI-assisted assembly · derived results

As of 2026-08-20, verified readiness is 32 (claimed 35, reported 35, gap 3) — Strong evidence strength; current signals suggest Too early to adopt.

The readiness fact belongs to the canonical Readiness Verdict for Life Biosciences ER-100 (Partial Epigenetic Reprogramming).

Dataset approval

Human editorial release

pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)

Dataset
2026-08-17.1
Hash
sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
Approved
2026-08-17

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.